Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 3 Tagen · Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to ...

  2. Vor 4 Tagen · Pfizer’s Lorbrena reduces rare lung cancer progression by 81%. New data being presented at ASCO on the long-approved Pfizer drug Lorbrena are remarkable: The daily pill decreased disease ...

  3. Vor 3 Tagen · Follow. May 31 (Reuters) - Pfizer (PFE.N) said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the strength of data presented on Friday showing most patients ...

  4. Vor 3 Tagen · A Pfizer lung cancer drug has been shown to greatly reduce tumour progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial results published on Friday. Lorlatinib, which is already approved and available under the brand name Lorbrena in the United States, was tested in a ...

  5. Vor 3 Tagen · A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial ...

  6. Vor 4 Tagen · According to the data, 61% of patients taking Lorbrena had no disease progression after five years, while only 8% of patients taking Pfizer’s older drug Xalkori were alive five years later with ...

  7. Vor 3 Tagen · Pfizers lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for years longer than other drugs, according to new research published Friday. The drug...